Jazz Pharmaceuticals plc JAZZ
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Jazz Pharmaceuticals plc is a biopharmaceutical company dedicated to identifying, developing, and commercializing innovative medicines that address unmet medical needs in serious diseases. It maintains a diverse portfolio of marketed products targeting rare epilepsies such as with Epidiolex, sleep disorders including n…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryIreland
Employees2,890
TickerJAZZ
Statistics
Market Cap$14.24B
Revenue (TTM)$4.27B
Net Income-$356.1M
Net Margin-8.3%
EPS$-5.84
P/E2087.55
P/S3.25
P/B3.18
EV/EBITDA8.44
ROE0.7%
Dividend Yield—
Price$227.06
Data: Twelve Data · Revenue = mcap / P/S